BPC 157 CURES CHROHNS DISEASE:
Scientific study that has been conducted on lab rats has shown that BPC 157 has the capability to lower the effects of inflammatory bowel disease; a collective of complex vascular tissue responses that are connected to the colon and small intestine. These conditions include:
Crohn’s disease – Also known as regional enteritis, this chronic inflammatory disorder can affect any part of the gastrointestinal tract from the mouth to the anus. It can cause abdominal pain, diarrhea, vomiting, dramatic loss of weight, and in some cases, anemia and arthritis.
Ulcerative colitis – This intermittent condition features inflammation of the colon as well as characteristic ulcers or open sores. Its primary symptom is constant diarrhea mixed with blood of gradual onset.
Collagenous colitis – This mild, intermittent condition is marked with characteristic inflammatory cells in the colon and frequent, watery diarrhea.